Treatment with cannabidiol led to improved seizure and nonseizure outcomes in patients with various forms of epilepsy, data show. The BECOME-TSC study evaluated outcomes of Epidiolex (Jazz ...

Advice for carers for people with epilepsy and a learning disability, including information on the link between epilepsy and ...

Pirates from across the country attended the funeral of a 14-year-old fan of all things swashbuckling. Billy Maskell, from ...

Massachusett-based Stoke Therapeutics STOK is making rapid progress with the development of zorevunersen (STK-001), its investigational candidate for treating Dravet syndrome, a severe and progressive ...

Parents of special needs children say they are disappointed but not surprised by proposed cuts as Ottawa’s largest school ...

Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four commercial assets by ...

and generalized epilepsy, and the POWER1 study in FOS. We are also thrilled to have received a third rare pediatric drug designation (RPDD) for relutrigine in Dravet Syndrome, and with strong interest ...

It does, however, treat Lennox-Gastaut syndrome (LGS) or Dravet syndrome. Those syndromes can develop in childhood, and most patients with LGS or Dravet require multiple seizure medications. The ...

This trial will investigate zorevunersen as a potential treatment for Dravet syndrome, a severe form of epilepsy in children. The study, slated to begin in mid-2025, will assess the efficacy of ...